^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    anti-CD138 CAR-T

    i
    Other names: anti-CD138 CAR-T
    Associations
    News
    Trials
    Company:
    Affiliated Hospital of Xuzhou Medical University
    Drug class:
    CD138-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials